drugset / Trial / NCT02470390

Open Label Crossover Study Pharmacokinetics (PK) Study in Healthy Volunteers Receiving Various Forms of Fentanyl

NCT02470390 ↗

Phase 4 Completed 13 enrolled Depomed
RandomizedCrossoverOpen-labelOther

Summary

A partially randomized, open-label, 3-way crossover, single-center, systemic and CSF PK and bioavailability study in healthy volunteers.

Timeline

Start
2014-11
Primary completion
2015-01
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 100 ug Intranasal
Comparator Fentanyl Other / unclassified 200 ug Intranasal

Indications

No indication recorded.